These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38215108)

  • 21. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of licartin combined with transcatheter hepatic arterial chemoembolization in the treatment of middle-advanced primary liver cancer.
    Jin J; Zhou T; Lou J; Yan S; Wu Y; Xie M; Wang W
    J BUON; 2020; 25(6):2584-2591. PubMed ID: 33455100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of a predictive model for short-term efficacy of transcatheter arterial chemoembolization treatment in hepatocellular carcinoma and its clinical application.
    Wei J; Wang Z
    J Cancer Res Ther; 2019; 15(4):941-946. PubMed ID: 31436256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Nishikawa H; Osaki Y; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Henmi S; Sakamoto A; Ishikawa T; Saito S; Kita R; Kimura T
    World J Gastroenterol; 2012 Mar; 18(12):1379-84. PubMed ID: 22493552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma.
    Aoki T; Imamura H; Hasegawa K; Matsukura A; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Arch Surg; 2004 Jul; 139(7):766-74. PubMed ID: 15249411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized nutritional intervention improves the nutritional status of liver cancer patients after transcatheter arterial chemoembolization.
    Sun Q; Yu H; You T; Zhang D
    Nutr Hosp; 2024 Jun; 41(3):649-656. PubMed ID: 38666338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects and safety of body positioning on back pain after transcatheter arterial chemoembolization in people with hepatocellular carcinoma: A randomized controlled study.
    Chang KT; Liu CJ; Tsai HT; Hsu TP; Chen PT; Hu SH
    Int J Nurs Stud; 2020 Sep; 109():103641. PubMed ID: 32535341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
    Huang YH; Wu JC; Chau GY; Lui WY; King KL; Chiang JH; Yen SH; Sheng WY; Hou MC; Lu CL; Chang FY; Lee SD
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):315-21. PubMed ID: 10333206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
    Li J; Wang N; Shi C; Liu Q; Song J; Ye X
    J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
    Zhang H; Yang A; Zhang J
    J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma.
    Cheng HY; Wang X; Chen D; Xu AM; Jia YC
    World J Gastroenterol; 2005 Jun; 11(23):3644-6. PubMed ID: 15962394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis.
    Chan KS; Tay WX; Cheo FY; Shelat VG
    Acta Chir Belg; 2023 Dec; 123(6):601-617. PubMed ID: 37681991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials.
    Si T; Chen Y; Ma D; Gong X; Yang K; Guan R; Peng C
    Scand J Gastroenterol; 2016 Dec; 51(12):1512-1519. PubMed ID: 27598831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
    Lee SH; Hahn ST; Park SH
    Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma.
    Liu Q; Dai Y
    J BUON; 2020; 25(2):945-951. PubMed ID: 32521890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.